First of all, we demonstrated that, in our experimental conditions, the difference in size and avidity for their target confer to (m) and (biv)anti-MMR Nbs a distinct behaviour, with (biv) Nbs having a longer circulatory half-life and less tumor penetration capability. Here, MRC1 is linked to neoplasm.